Earnings Call · Q4 FY2024·2024-12-17

Q4 24EPS -24.44%·Rev n/aQ3 24EPS -12.44%·Rev n/aQ2 24EPS -10.20%·Rev n/aQ1 24EPS 0.00%·Rev n/a⚠ consensus missing

NEUROONE MEDICAL TECHNOLOGIES Corp NMTC

Dave Rosa — Chief Executive Officer

Ron McClurg — Chief Financial Officer

+4.5%1d on move date+4.9% vs SPY3d+0.1%5d−2.0%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NMTC calls or request research access.

More NMTC calls Browse calls Request research access